Avenue Therapeutics Inc’s recently made public that its 10% Owner Davidow Robert L unloaded Company’s shares for reported $49600.0 on Dec 11 ’23. In the deal valued at $0.14 per share,353,000 shares were sold. As a result of this transaction, Davidow Robert L now holds 22,000 shares worth roughly $92400.0.
Then, Davidow Robert L sold 264,000 shares, generating $36,960 in total proceeds. Upon selling the shares at $0.14, the 10% Owner now owns 681,000 shares.
Before that, Fortress Biotech, Inc. bought 418,410 shares. Avenue Therapeutics Inc shares valued at $301,255 were divested by the 10% Owner at a price of $0.72 per share. As a result of the transaction, Fortress Biotech, Inc. now holds 1,032,390 shares, worth roughly $4.34 million.
Price Performance Review of ATXI
On Tuesday, Avenue Therapeutics Inc [NASDAQ:ATXI] saw its stock fall -6.87% to $4.20. Over the last five days, the stock has lost -16.17%. Avenue Therapeutics Inc shares have fallen nearly -65.22% since the year began. Nevertheless, the stocks have fallen -94.51% over the past one year. While a 52-week high of $93.75 was reached on 01/04/24, a 52-week low of $4.38 was recorded on 05/07/24. SMA at 50 days reached $10.21, while 200 days put it at $28.34. A total of 1.08 million shares were traded, compared to the trading of 58800.0 shares in the previous session.
Levels Of Support And Resistance For ATXI Stock
The 24-hour chart illustrates a support level at 3.50, which if violated will result in even more drops to 2.81. On the upside, there is a resistance level at 5.43. A further resistance level may holdings at 6.67. The Relative Strength Index (RSI) on the 14-day chart is 26.60, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.24, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.46%. Stochastics %K at 3.77% indicates the stock is a buying.
